August 26, 2015

Mylan this week announced the launch of its generic version of Pfizer’s Zosyn (piperacillin and tazobactam) injection.

August 26, 2015

Darren Townzen, Walmart’s director of health-and-wellness systems, and Sam’s Club’s John Luebker, senior director H&W wellness contracting and pricing, are the recipients of this year’s IMS Health Bernie Greenberg Pharmacy Partnership Award. 

August 22, 2015

An executive familiar with the kind of deep data dives that provide actionable insights for OTC companies joins CPR. 

August 21, 2015

The app allows users to find and download IMS Health data and white papers based on its analytics, healthcare expertise and global information assets.

August 20, 2015

Fifty years ago this summer, President Lyndon B. Johnson secured his place in history by signing into law the legislation that created Medicare and Medicaid. It was a landmark in the nation’s social and political development and an evolutionary leap for community pharmacy.

August 12, 2015

Dr. Reddy’s Laboratories has announced the launch and FDA approval of its pramipexole dihydrochloride extended release tablets.

August 5, 2015
Par Pharmaceutical announced Wednesday that the Food and Drug Administration had granted final approval of the company’s generic version of Sodium Edecrin (ethacrynate sodium) for injection.
July 9, 2015

Sandoz has launched its generic version of Angiomax (bivalirudin), an anticoagulant injection. 

April 25, 2015

Anda again hosted a stellar two-day event on the eve of NACDS Annual Meeting, featuring several notable sports celebrities, along with an industry overview from IMS Health’s Doug Long.

April 24, 2015

Sandoz on Friday announced the launch of levoleucovorin injection ready-to-use single use vial, a generic version of Fusilev, which is marketed by Spectrum Pharmaceuticals. 

April 17, 2015

IMS Health is getting ready to launch a consumer version of its AppScript app, according to a MedCityNews report. 

April 14, 2015

Total dollars spent on prescriptions in the U.S. were up 13.1%.

April 9, 2015

Walgreens Boots Alliance on Thursday posted solid same-store sales numbers, driving U.S. sales up 7.4% to $21 billion, but has targeted 200 store closures in a cost-saving initiative. 

March 13, 2015

“Drugs don’t work in patients who don’t take them.”

March 10, 2015

Actavis expanded its portfolio of topicals with the launch of a generic corticosteroid.

March 10, 2015

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.

February 9, 2015

Mylan Inc. and its subsidiary Mylan Pharmaceuticals are being sued by Bayer Healthcare, Bayer Healthcare Pharmaceuticals and Onyx Pharamceuticals in relation to the filing of an abbreviated new drug application for sorafenib tablets, the generic version of Nexavar. 

 

February 5, 2015

Generic drug prices are going up. Spurred by market opportunities, short-term market exclusivity for some newly launched single-source generics and rising costs for manufacturing, quality control and raw materials, me-too drug manufacturers have escalated a series of price hikes, some of them significant.

January 21, 2015

With specialty and biotech drugs claiming an ever-greater share of the pharmaceutical market and spawning a backlash from payers and patients over their high price tags, pharmacy operators are smack in the middle of a growing tug of war between the drug industry, the public and private health plans struggling to keep up with the new drug-cost paradigm.

January 7, 2015

The pharmaceutical industry is back. Fueled by the launch of expensive, new biotech medicines, rising prices for both branded and generic drugs and a recent slowdown in branded-drug patent expirations and generic competition, the U.S. pharmaceutical market is staging a remarkable resurgence.

December 22, 2014

Mylan has announced the U.S. launch of its Estradiol Transdermal System USP, 0.025 mg/day, 0.0375 mg/day, 0.05 mg/day, 0.075 mg/day and 0.1 mg/day (twice weekly), which is the generic version of Novartis' Vivelle-DOT.

December 1, 2014

November front-end drug store sales are expected to be comparable to last year while prescriptions dispensed will be up in the low single-digit range, reported Ed Kelly, Credit Suisse research analyst.

 

November 20, 2014

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

November 10, 2014

Sandoz last week announced the launch of a generic version of cyclophosphamide injection, USP. Sandoz is launching the drug through collaboration with Jiangsu Hengrui Medicine Co., which owns the product's abbreviated new drug application.